BeOne Medicines Expands U.S. Manufacturing with Total Investment of More Than $1 Billion to Advance Innovative Cancer Medicines

BeOne Medicines announced a $300 million expansion of its manufacturing and R&D center at the Princeton West Innovation Campus in Hopewell, NJ. The disclosed capex expansion is supportive of future capacity and development plans, though the news provides limited near-term financial detail.

Analysis

BeOne Medicines announced a $300 million expansion of its manufacturing and R&D center at the Princeton West Innovation Campus in Hopewell, NJ. The disclosed capex expansion is supportive of future capacity and development plans, though the news provides limited near-term financial detail.